| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| USD | 1,000.000 | 3.5 | Sep-22 | Sr. Unsecured | Baa2 | BBB+ | A | Fixed | Tsy | T+150-155 | T+145 | 145 | 3.63% | - | 99.94500 |
| USD | 300.000 | 3.5 | Sep-22 | Sr. Unsecured | Baa2 | BBB+ | A | Floating | 3mL | 3mL equiv | 3mL equiv | - | 3mL+140 | - | 100.00000 |
Tranche Comments
3.5 yr: Registration: 144A/Reg S; Comments: USD1bn 3.500yr 3.625% Fxd. bmk, snr unsec 144A/Reg S without registration rights. Baa2/BBB+/A. JPM/NatWest/RBC/SG. T+145 (the #). T+150/+155. T+145 GCP (Source: IFR);
3.5 yr: Registration: 144A/Reg S; Comments: USD3.500yr FRN. bmk, snr unsec 144A/Reg S without registration rights. Baa2/BBB+/A. JPM/NatWest/RBC/SG. 3mL equiv. 3ml equiv. GCP (Source: IFR);
Use of Proceeds
General corporate purposes